ATE121295T1 - Augentropfenarzneimittel. - Google Patents

Augentropfenarzneimittel.

Info

Publication number
ATE121295T1
ATE121295T1 AT91307275T AT91307275T ATE121295T1 AT E121295 T1 ATE121295 T1 AT E121295T1 AT 91307275 T AT91307275 T AT 91307275T AT 91307275 T AT91307275 T AT 91307275T AT E121295 T1 ATE121295 T1 AT E121295T1
Authority
AT
Austria
Prior art keywords
eye drops
medicinal products
benzoxadine
thioxo
cyclodextrin
Prior art date
Application number
AT91307275T
Other languages
English (en)
Inventor
Kazumichi Ushio
Yoshifumi Ikejiri
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE121295T1 publication Critical patent/ATE121295T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91307275T 1990-08-13 1991-08-08 Augentropfenarzneimittel. ATE121295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21482790 1990-08-13
JP16285491 1991-07-03

Publications (1)

Publication Number Publication Date
ATE121295T1 true ATE121295T1 (de) 1995-05-15

Family

ID=26488494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91307275T ATE121295T1 (de) 1990-08-13 1991-08-08 Augentropfenarzneimittel.

Country Status (16)

Country Link
US (1) US5663170A (de)
EP (1) EP0472327B1 (de)
JP (1) JP2769253B2 (de)
KR (1) KR920003971A (de)
AT (1) ATE121295T1 (de)
AU (1) AU633754B2 (de)
CA (1) CA2048942A1 (de)
DE (1) DE69109021T2 (de)
DK (1) DK0472327T3 (de)
ES (1) ES2071227T3 (de)
FI (1) FI97777C (de)
HU (1) HU207950B (de)
NO (1) NO177845C (de)
PT (1) PT98643B (de)
RU (1) RU2068260C1 (de)
TW (1) TW200402B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK143893A3 (en) * 1992-03-18 1994-05-11 Cooper Vision Pharmaceuticals Verapamil hci formulation and other opthalmic solutions with buffer system for ocular administration
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
WO1994010976A1 (en) * 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
SE501482C2 (sv) * 1993-06-24 1995-02-27 Leiras Oy Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning
WO1995003784A1 (en) * 1993-07-28 1995-02-09 Insite Vision Incorporated Suspensions for delivery of medicament
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
US5977180A (en) * 1994-07-11 1999-11-02 Pate; David W. Anandamide analog compositions and method of treating intraocular hypertension using same
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
DE69526369T2 (de) * 1995-01-20 2002-11-07 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
KR100261585B1 (ko) * 1995-01-20 2000-07-15 오쿠다 기요아키 항염증점안제
JP2002241272A (ja) * 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
JPH11209277A (ja) * 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
WO2000012137A1 (en) * 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
ES2263623T3 (es) * 2000-06-19 2006-12-16 Santen Pharmaceutical Co., Ltd. Agentes antisepticos.
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
US20100069335A1 (en) * 2005-07-15 2010-03-18 Rajiv Bhushan Prevention and Treatment of Ophthalmic Complications of Diabetes
US9486529B2 (en) 2012-03-26 2016-11-08 Santen Pharmceutical Co., Ltd. Ophthalmic solution comprising diquafosol
CA3097998A1 (en) * 2018-04-27 2019-10-31 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
US20230025836A1 (en) * 2019-11-21 2023-01-26 Samjin Pharmaceutical Co., Ltd. Eye drop composition for preventing or treating eye disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
AU8170891A (en) 1992-02-20
PT98643A (pt) 1992-07-31
FI97777B (fi) 1996-11-15
PT98643B (pt) 1999-01-29
NO913136D0 (no) 1991-08-12
DK0472327T3 (da) 1995-05-08
US5663170A (en) 1997-09-02
EP0472327A1 (de) 1992-02-26
ES2071227T3 (es) 1995-06-16
TW200402B (de) 1993-02-21
NO913136L (no) 1992-02-14
HU207950B (en) 1993-07-28
JP2769253B2 (ja) 1998-06-25
FI913811A (fi) 1992-02-14
HUT61196A (en) 1992-12-28
HU912692D0 (en) 1992-01-28
NO177845C (no) 1995-12-06
KR920003971A (ko) 1992-03-27
DE69109021D1 (de) 1995-05-24
AU633754B2 (en) 1993-02-04
RU2068260C1 (ru) 1996-10-27
FI913811A0 (fi) 1991-08-12
JPH05213757A (ja) 1993-08-24
FI97777C (fi) 1997-02-25
EP0472327B1 (de) 1995-04-19
DE69109021T2 (de) 1995-09-21
NO177845B (no) 1995-08-28
CA2048942A1 (en) 1992-02-14

Similar Documents

Publication Publication Date Title
ATE121295T1 (de) Augentropfenarzneimittel.
DE69010139T2 (de) Haarkräftigungsmittel.
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DE69121211T2 (de) Applanationstonometer
ES2024641B3 (es) Preservativo.
IL92187A0 (en) Anti-human immunodeficiency virus compositions comprising fluorine-containing pyridonecarboxylic acid derivatives
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
FI945510A (fi) Klavulaanihapon diamiinisuolat
DK0443848T3 (da) Nyt antiulcermiddel
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ZA834409B (en) 1,4-dihydropyridine derivatives in optically active or in racemate form and their production and pharmaceutical compositions
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
IL85517A (en) 3-(2-haloethyl)1,4-oxathiin and 2-(2-haloethyl)1,4-dithiin derivatives and pharmaceutical compositions containing the same
HUT57547A (en) Herbicidal compositions comprising n-phenylsulfonyl-n'-pyrimidinyl-urea derivatives as active ingredient and process for producing the active ingredient
HUT60737A (en) Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
FR2679139B1 (fr) Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.